DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. [electronic resource]
Producer: 20110805Description: 276-92 p. digitalISSN:- 1029-2470
- 2,6-Dichloroindophenol -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- genetics
- Caspases -- metabolism
- Cell Death
- Cell Line, Tumor
- Cell Proliferation
- DNA Damage
- Female
- Flow Cytometry
- Gene Expression Regulation, Neoplastic
- Glutathione -- metabolism
- Heat-Shock Proteins -- genetics
- Humans
- Immunoblotting
- Membrane Potential, Mitochondrial
- Mice
- NAD(P)H Dehydrogenase (Quinone) -- genetics
- Oxidative Stress
- Polymerase Chain Reaction
- Polymorphism, Single Nucleotide
- RNA, Small Interfering
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.